Apixaban
Brand name: Eliquis
Rank #1 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$7.75B
Total Cost
8,995,930
Total Claims
$7.75B
Total Cost
109,344
Prescribers
$862
Cost per Claim
1,867,503
Beneficiaries
14,347,700
30-Day Fills
$71K
Avg Cost/Provider
82
Avg Claims/Provider
Share of Medicare Part D Spending
2.8%
of total Medicare Part D spending
$7.75B of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $7.75B total
🔎 Data Overview
Apixaban is the #1 most expensive drug in Medicare Part D, costing taxpayers $7.75B in 2023. The top 10 drugs alone account for roughly 20% of all Part D spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Apixaban
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jennifer Tresser | Pharmacist | Martinez, CA | 3,613 | $5.8M |
| 2 | Elena Wellen | Pharmacist | Wilmington, NC | 1,784 | $2.9M |
| 3 | Jordan Wong | Pharmacist | San Francisco, CA | 1,771 | $2.5M |
| 4 | Carmen Wong | Pharmacist | Union City, CA | 1,729 | $2.5M |
| 5 | Mayer Rashtian | Clinical Cardiac Electrophysiology | Pasadena, CA | 2,071 | $2.5M |
| 6 | Hazar Dahhan | Cardiology | Manchester, CT | 1,598 | $2.1M |
| 7 | Zoheir Abdelbaki | Cardiology | Lima, OH | 1,816 | $2.1M |
| 8 | Lance Sullenberger | Cardiology | Albany, NY | 1,486 | $2.1M |
| 9 | Mark Ramos | Cardiology | Sarasota, FL | 1,662 | $2.0M |
| 10 | Robert Styperek | Cardiology | Rome, GA | 1,894 | $2.0M |
| 11 | Majed Nounou | Interventional Cardiology | Lapeer, MI | 1,605 | $2.0M |
| 12 | Sandeep Garg | Cardiology | Tualatin, OR | 1,704 | $1.8M |
| 13 | Alfonso Prieto | Clinical Cardiac Electrophysiology | Albany, NY | 1,325 | $1.8M |
| 14 | Hossein Amirani | Cardiology | Wichita, KS | 2,218 | $1.8M |
| 15 | Seth Mcclennen | Clinical Cardiac Electrophysiology | South Weymouth, MA | 1,255 | $1.8M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 1 | Apixaban (Eliquis) | $7.75B | 8,995,930 |
| 2 | Semaglutide (Ozempic) | $4.30B | 3,193,643 |
| 3 | Empagliflozin (Jardiance) | $3.58B | 3,334,784 |
| 4 | Dulaglutide (Trulicity) | $2.99B | 2,175,100 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology